TKNO Alpha Teknova, Inc. Common Stock
XNAS
6.59
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $1.91 – $9.48
- YTD
- +68.97%
- IV Rank (30D)
- 4.35
- Straddle Price
- $1.78
- P/C Vol Ratio
- 4.67
- Market Cap
- $0.4B
- Open
- $6.30
- Day Range
- $6.30 – $6.72
- Volume
- 678,305
- Prev Close
- $6.42
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.96% |
| Beta vs SPY | 1.11 |
| Cost of Equity (CAPM) | 11.07% (VRP-adj) |
| WACC | 10.99% |
| Volatility Risk Premium | +98.5pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 21.0% |
| Rev. Growth (YoY, DCF input) | +16.6% |
| DCF Horizon | 10 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.10 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $-0.0B |
| Return on Equity (TTM) | -26.8% |
| Book / Price | 17.7% |
| Gross Margin (TTM) | 34.6% |
| FCF Margin (TTM) | -16.8% |
| Debt / Equity | 0.21 |
| Quality Score | 2/6 — normal (10y DCF) |
| SMA 50 | $7.67 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $7.91 |
| Bollinger Width / SMA20 | 677.3% (drives anchor stability) |
| Net Debt | $0.0B |
| Market Cap | $0B |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | n/a | 0% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | n/a | 0% | median 30.1× · 5 peers |
| Peer EV/EBITDA | n/a | 0% | median 21.9× · 6 peers |
| Peer P/B | $15.90 | 50% | median 13.6× · 8 peers |
| Peer P/S | $5.60 | 50% | median 6.2× · 7 peers |
| Market Anchor (SMA50) | $7.67 | 0% | stability 0% (BB-width) |
| Options Expected (B-L 30d) | $5.71 | 0% | 5 strikes · skew +0.54 |
- Industry (SIC)
- IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES (2835) · industry map
- Exchange
- XNAS
- Market Cap
- $0.4B
- Employees
- 158
- List Date
- 2021-06-25
- CIK
- 0001850902
- Next Earnings
- 2026-11-04 (After-Close)
- EPS Forecast
- ($0.06) (2 est.)
- Headquarters
- Hollister, CA
- Homepage
- https://www.teknova.com
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | -- | -27.08% | 6.05% | -15.53% | 6.25% | -37.95% | -13.65% |
| Feb | -- | 7.73% | -9.21% | -11.96% | -29.35% | 8.86% | -6.79% |
| Mar | -- | -18.86% | -42.41% | -7.34% | -11.43% | 21.43% | -11.72% |
| Apr | -- | -22.34% | -34.60% | -36.65% | 28.52% | 21.16% | -8.78% |
| May | -- | -32.12% | 112.15% | -7.85% | -12.71% | 58.82% | 23.66% |
| Jun | -5.08% | 8.39% | -31.36% | -25.54% | -14.31% | 5.77% | -10.35% |
| Jul | -9.34% | -20.47% | 27.92% | 210.74% | -8.32% | -15.82% | 30.79% |
| Aug | -17.71% | -33.19% | -39.81% | 39.15% | 1.89% | 35.47% | -2.37% |
| Sep | 34.11% | -24.43% | 52.46% | 6.37% | 46.34% | 25.71% | 23.43% |
| Oct | -13.96% | 31.14% | -20.72% | 49.45% | -17.58% | -25.62%* | 0.45% |
| Nov | -2.78% | -0.42% | 6.25% | 5.81% | -7.87% | -- | 0.20% |
| Dec | 0.89% | 16.29% | 62.17% | 13.61% | -18.45% | -- | 14.90% |
| Total | -19.85% | -77.79% | -15.32% | 147.50% | -45.90% | 78.01% | 11.11% |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
Here is a comprehensive stock analysis report for TKNO:
Executive Summary
Overall assessment: NEUTRAL with confidence level (6/10)
Key drivers: Technical momentum, earnings expectations, industry trends
Primary risks: Volatility, regulatory changes, competition
2-3 sentence investment thesis: TKNO has been trending upward, driven by technical momentum and positive news sentiment. While there are some concerns about volatility and regulatory risk, the stock's recent strength suggests a potentially bullish outlook.
Recent news sentiment impact: The positive news headlines have contributed to TKNO's recent price move, with investors responding favorably to developments in the company's cell therapy initiatives.
Technical Analysis
Trend Direction: Medium-term (1-3 months)
Support/Resistance Levels:
- Upper Bollinger Band: $4.14
- Middle Line: $3.70
- Lower Bollinger Band: $3.26
Momentum Signals:
- RSI interpretation: Neutral (63.01) - neither overbought nor oversold
- MACD signal: Bullish (0.20 / Signal: -0.01)
- Bollinger Bands position: Squeeze (price touching upper band)
Volume Analysis:
- Volume SMA 20: 107911.80
- On-Balance Volume (OBV): 20264620.90
News & Sentiment Analysis
Recent Headlines Summary: The company has announced several positive developments, including collaborations with Pluristyx and a launch of proprietary build-Tek solutions.
Sentiment Assessment: Positive sentiment dominates the recent news headlines, with investors responding favorably to these developments.
Catalyst Identification: Upcoming earnings announcements may provide additional catalysts for the stock's price movement.
Market Narrative: The positive news sentiment aligns with the technical momentum signals, suggesting a potentially bullish outlook.
Risk & Volatility Assessment
Beta Interpretation: High risk relative to market (beta 1.52 vs SPY)
Volatility Regime: Current volatility is higher than historical levels.
Options Market Signals:
- IV Rank: Medium (44.0%)
- Put/Call Volume Ratio: 0.00 (Bullish sentiment)
- Open Interest: 15 calls vs 0 puts
Downside Protection:
- Support levels: Lower Bollinger Band ($3.26) and SMA 50 ($3.24)
Market Context & Positioning
Sector Performance: TKNO has outperformed the sector, with a relative strength index (RSI) of 71.6%.
Institutional Activity: Institutional investors have been buying shares, as seen in the recent Telegraph Hill Partners purchase.
Correlation Analysis: TKNO's correlation with the market is relatively low (R-squared interpretation).
Relative Valuation: The stock trades at a premium valuation relative to its historical trading range.
Key Levels & Action Items
Critical Price Levels:
- Upper Bollinger Band: $4.14
- Middle Line: $3.70
- Lower Bollinger Band: $3.26
Breakout/Breakdown Levels:
- SMA 50: $3.24 (potential breakdown)
- EMA 12: $3.77 (potential breakout)
Time-Sensitive Catalysts:
- Upcoming earnings announcements (date TBA)
Risk Management:
- Stop-loss levels: Below the Lower Bollinger Band ($3.26) or SMA 50 ($3.24)
- Position sizing considerations: Consider reducing position size to manage risk.
Please note that this analysis is based on the provided data and should not be taken as investment advice.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2025-11-06 | Pre-Market | 52.02% | 2.83% | 0.05x | Within |
| 2026-02-26 | Pre-Market | 123.89% | 0.88% | 0.01x | Within |
| 2026-05-06 | After-Close | 54.26% | 9.89% | 0.18x | Within |
| 2026-08-05 | Pre-Market | 35.78% | 1.63% | 0.05x | Within |
| 2026-10-21 | Pre-Market | 23.00% | 20.84% | 0.91x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
TKNO Options Activity & IV Rank
TKNO IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Options Flow
ATM Options Pricing
Chain Summary
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Estimated net dealer gamma is at the 8th percentile of this name's own daily history, near the low end of its range. This describes current positioning; it is not a forecast or a trading signal.
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
Risk Metrics
Analysis Details
Data Points: 251
Period: 252 trading days
Above average volatility - stock moves with market amplification
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Millennium Management Hedge fund Izzy Englander | $426K | #3238 of 3716 | -83.2% | 13F | |
| Citadel Hedge fund Ken Griffin | $134K | #5659 of 6285 | -60.9% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
TKNO Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Simplex Trading, LLC Custodian | $17.04K | 100.00% | 2026-06-30 |
| # | Filer | Notional Value | % of Total | Period |
|---|
TKNO Insider Trading (Form 4)
Latest: 2026-07-16| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-07-16 | Martha J Demski | Director | Other (J) | 12,000 (reclass) | — | EDGAR | |
| 2026-06-02 | Brett Robertson | Director | Grant (A) | +55,000 opt | — | EDGAR | |
| 2026-06-02 | Martha J Demski | Director | Grant (A) | +55,000 opt | — | EDGAR | |
| 2026-06-02 | Alexander Vos | Director | Grant (A) | +55,000 opt | — | EDGAR | |
| 2026-03-09 | Stephen Gunstream | President and CEO | Buy (P) | +26,000 | $2.15 | $55.8K | EDGAR |
| 2026-03-09 | Matthew Lowell | Chief Financial Officer | Buy (P) | +40,000 | $2.19 | $87.6K | EDGAR |
| 2026-03-09 | Damon Terrill | General Counsel and CCO | Grant (A) | +148,000 opt | — | EDGAR | |
| 2025-07-01 | Martha J Demski | Director | Grant (A) | +54,300 opt | — | EDGAR | |
| 2025-07-01 | Martha J Demski | Director | Sell (S) | −8,000 | $5.06 | -$40.5K | EDGAR |
| 2025-07-01 | Alexander Vos | Director | Grant (A) | +54,300 opt | — | EDGAR | |
| 2025-07-01 | Brett Robertson | Director | Grant (A) | +54,300 opt | — | EDGAR | |
| 2025-06-25 | Martha J Demski | Director | Award (A) | +54,300 | — | EDGAR | |
| 2025-06-25 | Damon Terrill | General Counsel and CCO | Grant (A) | +137,808 opt | — | EDGAR | |
| 2025-06-25 | Alexander Vos | Director | Award (A) | +54,300 | — | EDGAR | |
| 2025-06-25 | Matthew Lowell | Chief Financial Officer | Grant (A) | +169,857 opt | — | EDGAR |
TKNO Insider Holdings
6 insiders · @ $6.59| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Stephen Gunstream | President and CEO | 269,497 | $1.78M | $377.3K | 10 | 2026-03-09 |
| 2 | Matthew Lowell | Chief Financial Officer | 168,376 | $1.11M | $378.2K | 10 | 2026-03-09 |
| 3 | Brett Robertson | Director | 107,472 | $708.2K | $0 | 8 | 2026-06-02 |
| 4 | Alexander Vos | Director | 102,472 | $675.3K | $0 | 7 | 2026-06-02 |
| 5 | Damon Terrill | General Counsel and CCO | 41,027 | $270.4K | $50.0K | 6 | 2026-03-09 |
| 6 | Martha J Demski | Director | 12,000 | $79.1K | -$40.5K | 7 | 2026-07-16 |
TKNO Board & Officers
As of SEC filings through Jul 16, 2026Directors 6
- Alexander C. Herzick · since Jun 24, 2021
- Alexander Vos · since Jun 24, 2021
- Brett Robertson · since Jun 24, 2021
- J Matthew Mackowski · since Jun 24, 2021
- Stephen Gunstream · since Jun 24, 2021
- Martha J Demski · since Aug 31, 2023
Officers 3
- Stephen Gunstream · President and CEO · since Jun 24, 2021
- Matthew Lowell · Chief Financial Officer · since Jun 24, 2021
- Damon Terrill · General Counsel and CCO · since Jun 24, 2021
Changes in the last 10 years (24)
| Jun 26, 2024 | The company announced the departure of Ted Davis from the board in an SEC filing |
| Aug 31, 2023 | Martha J Demski became a director |
| Jul 6, 2023 | The company announced the departure of Robert McNamara from the board in an SEC filing |
| Nov 15, 2021 | Ken Gelhaus became Chief Commercial Officer |
| Aug 26, 2021 | Ted Davis first listed as a 10% owner in an SEC filing |
| Aug 26, 2021 | Irene Davis first listed as a 10% owner in an SEC filing |
| Jun 24, 2021 | Telegraph Hill Partners Management Company, LLC became a 10% owner |
| Jun 24, 2021 | Telegraph Hill Partners IV, L.P. became a 10% owner |
| Jun 24, 2021 | Telegraph Hill Partners IV Investment Management LLC became a 10% owner |
| Jun 24, 2021 | Ted Davis became a director |
| Jun 24, 2021 | THP IV Affiliates Fund, LLC became a 10% owner |
| Jun 24, 2021 | Stephen Gunstream became a director |
| Jun 24, 2021 | Stephen Gunstream became President and CEO |
| Jun 24, 2021 | Robert McNamara became a director |
| Jun 24, 2021 | Paul David Grossman became a director |
| Jun 24, 2021 | Neal Goodwin became Chief Scientific Officer |
| Jun 24, 2021 | Matthew Lowell became Chief Financial Officer |
| Jun 24, 2021 | Lisa Hood became Chief People Officer |
| Jun 24, 2021 | J Matthew Mackowski became a director |
| Jun 24, 2021 | Irene Davis became a director |
| Jun 24, 2021 | Damon Terrill became General Counsel and CCO |
| Jun 24, 2021 | Brett Robertson became a director |
| Jun 24, 2021 | Alexander Vos became a director |
| Jun 24, 2021 | Alexander C. Herzick became a director |
- Prev
- 1
Not reported recently (10)
- Telegraph Hill Partners IV Investment Management LLC · Last reported as a 10% owner in an SEC filing dated Jul 16, 2024
- Telegraph Hill Partners Management Company, LLC · Last reported as a 10% owner in an SEC filing dated Jul 16, 2024
- Telegraph Hill Partners IV, L.P. · Last reported as a 10% owner in an SEC filing dated Jul 16, 2024
- THP IV Affiliates Fund, LLC · Last reported as a 10% owner in an SEC filing dated Jul 16, 2024
- Paul David Grossman · Last reported as a director in an SEC filing dated Jun 24, 2024
- Ken Gelhaus · Last reported as Chief Commercial Officer in an SEC filing dated Dec 1, 2023
- Lisa Hood · Last reported as Chief People Officer in an SEC filing dated Nov 15, 2023
- Irene Davis · Last reported as a director in an SEC filing dated Jun 13, 2023
- Ted Davis · Last reported as a 10% owner in an SEC filing dated May 31, 2023
- Neal Goodwin · Last reported as Chief Scientific Officer in an SEC filing dated Jun 24, 2021
TKNO Proposed Insider Sales (Form 144)
Latest: 2023-06-13What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2023-06-13 | Hood Lisa | Officer | 11,400 | $43.3K | 2023-06-13 | ETRADE FINANCIAL CORPORATION | — | EDGAR |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $13.1M | — | 2026-09-30 |
| 2 | IWM iShares Russell 2000 ETF | iShares (BlackRock) | 0.00% | $1.9M | $74.6B | 2026-10-23 |
| 3 | VXF Vanguard Extended Market ETF | Vanguard | 0.00% | $1.1M | — | 2026-09-30 |
| 4 | IWN iShares Russell 2000 Value ETF | iShares (BlackRock) | 0.00% | $608,179 | $13.9B | 2026-10-23 |
| 5 | VTWO Vanguard Russell 2000 ETF | Vanguard | 0.00% | $575,839 | — | 2026-09-30 |
| 6 | IBB iShares Biotechnology ETF | iShares (BlackRock) | 0.01% | $533,881 | $10.7B | 2026-10-23 |
| 7 | AVSC Avantis U.S. Small Cap Equity ETF | Avantis | 0.01% | $235,858 | $3.2B | 2026-10-23 |
| 8 | IWC iShares Micro-Cap ETF | iShares (BlackRock) | 0.02% | $221,541 | $1.2B | 2026-10-23 |
| 9 | VTWV Vanguard Russell 2000 Value ETF | Vanguard | 0.01% | $84,052 | — | 2026-09-30 |
| 10 | RSSL Global X Russell 2000 ETF | Global X | 0.00% | $35,467 | — | 2026-10-26 |
| 11 | IBBQ Invesco Nasdaq Biotechnology ETF | Invesco | 0.02% | $26,309 | — | 2026-10-24 |
| 12 | DCOR Dimensional US Core Equity 1 ETF | Dimensional | 0.00% | $17,604 | — | 2026-10-23 |
| 13 | BIB ProShares Ultra NASDAQ Biotechnology | ProShares | 0.01% | $14,129 | — | 2026-10-26 |
| 14 | VTWG Vanguard Russell 2000 Growth ETF | Vanguard | 0.00% | $12,789 | — | 2026-09-30 |
| 15 | DFAS Dimensional US Small Cap ETF | Dimensional | 0.00% | $11,023 | — | 2026-10-23 |
| 16 | VTHR Vanguard Russell 3000 ETF | Vanguard | 0.00% | $8,161 | — | 2026-09-30 |
| 17 | ITWO ProShares Russell 2000 High Income ETF | ProShares | 0.00% | $4,211 | — | 2026-10-26 |
| 18 | URTY ProShares UltraPro Russell2000 | ProShares | 0.00% | $3,236 | — | 2026-10-26 |
| 19 | UWM ProShares Ultra Russell2000 | ProShares | 0.00% | $2,274 | — | 2026-10-26 |
| 20 | IWO iShares Russell 2000 Growth ETF | iShares (BlackRock) | 0.00% | $578 | $13.7B | 2026-10-23 |
| 21 | HDG ProShares Hedge Replication ETF | ProShares | 0.00% | $92 | — | 2026-10-26 |
| 22 | RB ProShares Russell 2000 Dynamic Buffer ETF | ProShares | 0.00% | $40 | — | 2026-10-26 |
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q2 '26 | 2026-06-30 | $12.19M | $-3.17M | $-0.06 | $-471.00K |
| Q1 '26 | 2026-03-31 | $11.08M | $-4.55M | $-0.08 | $-3.36M |
| Q4 '25 | 2025-12-31 | $9.98M | $-4.76M | $-0.09 | $-462.00K |
| Q3 '25 | 2025-09-30 | $10.45M | $-4.29M | $-0.08 | $-1.98M |
| Q2 '25 | 2025-06-30 | $10.29M | $-3.57M | $-0.07 | $-2.10M |
| Q1 '25 | 2025-03-31 | $10.28M | $-4.64M | $-0.09 | $-4.10M |
| Q4 '24 | 2024-12-31 | $9.27M | $-5.72M | $-0.10 | $-936.00K |
| Q3 '24 | 2024-09-30 | $9.58M | $-7.57M | $-0.15 | $-2.06M |
| Q2 '24 | 2024-06-30 | $9.61M | $-5.36M | $-0.13 | $-2.84M |
| Q1 '24 | 2024-03-31 | $9.29M | $-8.10M | $-0.20 | $-6.56M |
| Q4 '23 | 2023-12-31 | $7.87M | $-10.66M | $-0.25 | $-2.89M |
| Q3 '23 | 2023-09-30 | $8.17M | $-10.15M | $-0.34 | $-4.38M |
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.